Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19
Annabelle Dupont(Inserm), Sophie Susen(Inserm), Julien Labreuche(ASTER), Julien Poissy(Centre National de la Recherche Scientifique), Mickaël Rosa(Lung Institute), Delphine Garrigue(Society of Critical Care Medicine), Delphine Corseaux(Inserm), Anne Bauters(Centre Hospitalier Universitaire de Lille), Senna Staessens(Research Institute for Chromatography), Fanny Lassalle(Inserm), Guillaume Lefèvre(Centre National de la Recherche Scientifique), Éric Kipnis(Centre National de la Recherche Scientifique), Emmanuelle Jeanpierre(Inserm), Antoine Rauch(Inserm), Peter J. Lenting(Université Paris-Sud), Natacha Rousse(Inserm), Simon F. De Meyer(Research Institute for Chromatography), Morgan Caplan(Centre Hospitalier Universitaire de Lille), Mouhamed Djahoum Moussa(Inserm), Pauline Varlet(Inserm), Flavien Vincent(Inserm), Karine Faure(Inserm), Alain Duhamel(Université de Lille), Bart Staels(National Institutes of Health), M. Lambert(Hôpital Claude Huriez), Julien Goutay(Centre Hospitalier Universitaire de Lille)
Cited by 114
Related Papers
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
|Journal of Hepatology|2014|1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
|Journal of Biological Chemistry|1999|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901